User: Guest  Login
Title:

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Document type:
Zeitschriftenaufsatz
Author(s):
Rugo, H. S.; Finn, R. S.; Diéras, V.; Ettl, J.; Lipatov, O.; Joy, A. A.; Harbeck, N.; Castrellon, A.; Iyer, S.; Lu, D. R.; Mori, A.; Gauthier, E. R.; Bartlett, C. Huang; Gelmon, K. A.; Slamon, D. J.
Journal title:
Breast Cancer Research and Treatment
Year:
2019
Journal volume:
174
Journal issue:
3
Pages contribution:
719-729
Fulltext / DOI:
doi:10.1007/s10549-018-05125-4
Publisher:
Springer Science and Business Media LLC
E-ISSN:
0167-68061573-7217
Date of publication:
10.01.2019
 BibTeX